These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35372881)

  • 41. COVID-19 - A Kidney Perspective.
    Tang J
    R I Med J (2013); 2020 Sep; 103(8):19. PubMed ID: 32900006
    [No Abstract]   [Full Text] [Related]  

  • 42. Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages.
    Ammar MA; Sacha GL; Welch SC; Bass SN; Kane-Gill SL; Duggal A; Ammar AA
    J Intensive Care Med; 2021 Feb; 36(2):157-174. PubMed ID: 32844730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 mortality and ICU admission: the Italian experience.
    Immovilli P; Morelli N; Antonucci E; Radaelli G; Barbera M; Guidetti D
    Crit Care; 2020 May; 24(1):228. PubMed ID: 32414403
    [No Abstract]   [Full Text] [Related]  

  • 44. Decreasing mortality rates in ICU during the COVID-19 pandemic.
    Armstrong RA; Kane AD; Cook TM
    Anaesthesia; 2021 Mar; 76 Suppl 3(Suppl 3):10. PubMed ID: 32776536
    [No Abstract]   [Full Text] [Related]  

  • 45. ICU survivorship: What PAs need to know.
    LaRosa N
    JAAPA; 2021 Sep; 34(9):25-29. PubMed ID: 34448773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Communication in the ICU during the COVID-19 pandemic.
    Barreras-Espinoza JA; Leyva-Moraga FA; Leyva-Moraga E; Leyva-Moraga F; Soualhi A; Juanz-González A; Urquijo M; Burgos-Claudio MI; Ocejo-Gallegos JA; Ibarra-Celaya JM; Sloper W; Castillo-Ortega G
    Eur J Anaesthesiol; 2021 Oct; 38(10):1009-1011. PubMed ID: 34524156
    [No Abstract]   [Full Text] [Related]  

  • 47. Implications of the COVID-19 Pandemic for the Well-Being of the ICU Workforce Considerations for the ICU Interprofessional Team.
    Kho ME; Reid JC
    Chest; 2022 Aug; 162(2):285-287. PubMed ID: 35940650
    [No Abstract]   [Full Text] [Related]  

  • 48. Higher Than Expected Severity-Adjusted Mortality in ICU Patients With Coronavirus Disease 2019: Time to Consider the Contributions of Pandemic-Related Transformations in Structure and Process.
    Oud L
    Crit Care Med; 2021 Dec; 49(12):e1260-e1261. PubMed ID: 34166294
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhancing family-centered care in the ICU during the COVID-19 pandemic.
    Rasheed AM; Mhawish HA; Asa'Ad DS; Almuabbadi B; Amirah MF; Alshammari B; Aldamaeen A; Alharthy A
    Nurs Manage; 2021 Aug; 52(8):34-38. PubMed ID: 34397670
    [No Abstract]   [Full Text] [Related]  

  • 50. Video calls at end of life are feasible but not enough: A 1-year intensive care unit experience during the coronavirus disease-19 pandemic.
    Galazzi A; Binda F; Gambazza S; Lusignani M; Grasselli G; Laquintana D
    Nurs Crit Care; 2021 Nov; 26(6):531-533. PubMed ID: 33955111
    [No Abstract]   [Full Text] [Related]  

  • 51. Beware of serotonin syndrome during the COVID-19 pandemic.
    Nagamine T
    Aust N Z J Psychiatry; 2022 Jul; 56(7):862. PubMed ID: 35360972
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of the delirium risk prediction model in the TED ICU smart intensive care system during the current COVID-19 pandemic.
    Ho MH; Shen SH
    Intensive Crit Care Nurs; 2021 Apr; 63():103007. PubMed ID: 33358600
    [No Abstract]   [Full Text] [Related]  

  • 53. Considerations on ICU triage ethics during the COVID-19 pandemic.
    Monzón Marín JL; Couceiro Vidal A
    Med Intensiva (Engl Ed); 2021; 45(6):381-382. PubMed ID: 34294237
    [No Abstract]   [Full Text] [Related]  

  • 54. Consequences of visitor restriction policies in the intensive care unit during the COVID-19 pandemic.
    Honarmand K; Mehta S
    Can J Anaesth; 2021 Oct; 68(10):1465-1470. PubMed ID: 34212307
    [No Abstract]   [Full Text] [Related]  

  • 55. Reply to "Considerations on ICU triage ethics during the COVID-19 pandemic".
    Rubio O; Cabré L; Estella A; Ferrer R
    Med Intensiva (Engl Ed); 2021; 45(6):382. PubMed ID: 34294238
    [No Abstract]   [Full Text] [Related]  

  • 56. Successful provision of CAR-T therapy during a pandemic: low SARS-CoV-2 infection rates and reduction in ICU admissions following modification of patient pathway.
    Carter-Brzezinski L; Davies E; Norman J; Rubio L; Dixon C; Brett S; Dunne T; Iqbal S; Dignan FL; Ahmad S; Machin N; Morriss H; Wilson A; Tholouli E
    Leuk Lymphoma; 2022 Dec; 63(13):3265-3267. PubMed ID: 35994619
    [No Abstract]   [Full Text] [Related]  

  • 57. Coronavirus Disease 2019 Intermediate Care Units: Containing Escalation of ICUs.
    González-Calle D; Villacorta E; Sánchez-Serrano A; León M; Sanchez PL
    Crit Care Med; 2020 Dec; 48(12):e1372-e1374. PubMed ID: 32804786
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter to the Editor: "The impact of COVID-19 pandemic on the initiation of interventional clinical trials conducted in intensive care units".
    Huang C; Gao S; Barwise AK; Lai X; Huang W; Xiao Y; Wang Z
    J Crit Care; 2022 Jun; 69():154019. PubMed ID: 35290933
    [No Abstract]   [Full Text] [Related]  

  • 59. Surviving the COVID-19 Pandemic from the Pediatric Surgical Perspective: Innovations in Risk Mitigation and Scarce Resource Management.
    Mak GZ; Slidell MB
    Pediatr Ann; 2022 Jul; 51(7):e264-e265. PubMed ID: 35858221
    [No Abstract]   [Full Text] [Related]  

  • 60. Disparities in risk stratification guidance for patients taking immunosuppressive drugs during the COVID-19 pandemic - points to ponder.
    Nune A; Ish P; Iyengar KP; Mago A; Khan N; Raj Sapkota H
    J R Coll Physicians Edinb; 2022 Jun; 52(2):185-187. PubMed ID: 36147005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.